BGMD (BG Medicine) ROE % Adjusted to Book Value: 0.00% (As of Dec. 2015)


What is BG Medicine ROE % Adjusted to Book Value?

BG Medicine BGMD -99.00% ROE % Adjusted to Book Value is 0.00% as of Dec. 2015.

BG Medicine's ROE % for the quarter that ended in Dec. 2015 was 0.00%. BG Medicine's PB Ratio for the quarter that ended in Dec. 2015 was N/A. BG Medicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2015 was N/A.

BG Medicine ROE % Adjusted to Book Value Related Terms

BG Medicine ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for BG Medicine's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BG Medicine ROE % Adjusted to Book Value Chart

BG Medicine Annual Data
Trend Dec05 Dec06 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1.46 0.00 0.00 0.00

BG Medicine Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.52 0.00 0.00 0.00 0.00

BGMD vs LENSF, WHSI, ASNB: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, BG Medicine's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BG Medicine ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BG Medicine's ROE % Adjusted to Book Value falls into.


BG Medicine ROE % Adjusted to Book Value Calculation

BG Medicine's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2015 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

BG Medicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2015 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
BG Medicine (BGMD) has a ROE % Adjusted to Book Value of 0.00% as of Dec. 2015. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BG Medicine and its competitors.
Is BG Medicine's ROE % Adjusted to Book Value too high?
BG Medicine's current ROE % Adjusted to Book Value is 0.00%.
How does BG Medicine's ROE % Adjusted to Book Value compare to LENSF and WHSI?
BG Medicine's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BG Medicine and its competitors. BG Medicine's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BG Medicine stock overvalued right now?
BG Medicine (BGMD) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For BG Medicine (BGMD), the current ROE % Adjusted to Book Value is 0.00% as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BG Medicine Business Description

Address 303 Wyman Street, Suite 300, Waltham, MA, USA, 02451
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.